Simone Rivolo

5PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersEconometric and statistical methodsInfant and child healthCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 07, 2026
Transportability of tislelizumab trial outcomes from RATIONALE-315, RATIONALE-303, and RATIONALE-312 to the European population in early-stage non-small cell lung cancer (NSCLC), advanced NSCLC and extensive-stage small cell lung cancer (ES-SCLC).

|Sep 05, 2024
Authors' response to a critical appraisal on "Assessing the cost-effectiveness of once-weekly somatrogon vs. daily somatropin for pediatric growth hormone deficiency".

Simone Rivolo, Balazs Peter, Marion Fahey

|Aug 01, 2023
Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland.

Simone Rivolo, Jane Loftus, Balazs Peter

|Nov 12, 2021
Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.

Simone Rivolo, Manuela Di Fusco, Carlos Polanco

|Aug 03, 2021
Effect of Percutaneous Left Ventricular Unloading on Coronary Flow and Cardiac Coronary Coupling in Patients Undergoing High-Risk Percutaneous Coronary Intervention.

Natalia Briceno, Matthew Ryan, Kevin O'Gallagher

Pageof 1

Frequent Collaborators

2 joint publications

Balazs Peter

1 joint publications

Natalia Briceno

1 joint publications

Kevin O'Gallagher

1 joint publications

Tiffany Patterson